Abstract
Vasopressin (AVP) induces antidiuresis, thus playing an essential role in body water and electrolyte homeostasis. Its antidiuretic effects are mediated chiefly by V2 vasopressin receptors (V2R) expressed along the distal nephron and collecting duct epithelia. NaCl reabsorption in the distal nephron, which includes the thick ascending limb (TAL) and distal convoluted tubule (DCT), largely depends on the activity of two structurally related Na-(K)-Cl cotransporters, NKCC2 in TAL and NCC in DCT. AVP-induced activation of these transporters contributes to urine concentration and renal electrolyte reabsorption. Previous work has specified molecular pathways mediating the effects of V2R activation in TAL and DCT, and protein networks involved in intracellular trafficking and phosphoregulation of the two transporters have been identified. This review summarizes recent progress in understanding AVP signalling mechanisms that are responsible for the activation of NKCC2 and NCC. Implications in the pathophysiology of diseases such as nephrogenic diabetes insipidus, diabetes mellitus and salt-sensitive hypertension are discussed in this context.
Similar content being viewed by others
References
Acuña R, Martínez-de-la-Maza L, Ponce-Coria J, Vázquez N, Ortal-Vite P, Pacheco-Alvarez D, Bobadilla NA, Gamba G (2011) Rare mutations in SLC12A1 and SLC12A3 protect against hypertension by reducing the activity of renal salt cotransporters. J Hypertens 29:475–483. doi:10.1097/HJH.0b013e328341d0fd
Aoyagi T, Izumi Y, Hiroyama M, Matsuzaki T, Yasuoka Y, Sanbe A, Miyazaki H, Fujiwara Y, Nakayama Y, Kohda Y, Yamauchi J, Inoue T, Kawahara K, Saito H, Tomita K, Nonoguchi H, Tanoue A (2008) Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Ren Physiol 295:F100–F107. doi:10.1152/ajprenal.00088.2008
Bachmann S, Bostanjoglo M, Schmitt R, Ellison DH (1999) Sodium transport-related proteins in the mammalian distal nephron—distribution, ontogeny and functional aspects. Anat Embryol (Berl) 200:447–468
Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H (1997) Role of vasopressin in essential hypertension: racial differences. J Hypertens 15:545–550
Bankir L (2001) Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 51:372–390
Bankir L, Bouby N, Ritz E (2013) Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol 9:223–239. doi:10.1038/nrneph.2013.22
Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG (2005) Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol JASN 16:1920–1928. doi:10.1681/ASN.2004121079
Bankir L, Perucca J, Weinberger MH (2007) Ethnic differences in urine concentration: possible relationship to blood pressure. Clin J Am Soc Nephrol CJASN 2:304–312. doi:10.2215/CJN.03401006
Bardoux P, Bruneval P, Heudes D, Bouby N, Bankir L (2003) Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant 18:1755–1763
Bardoux P, Martin H, Ahloulay M, Schmitt F, Bouby N, Trinh-Trang-Tan MM, Bankir L (1999) Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci U S A 96:10397–10402
Bazúa-Valenti S, Castañeda-Bueno M, Gamba G (2016) Physiological role of SLC12 family members in the kidney. Am J Physiol Ren Physiol 311:F131–F144. doi:10.1152/ajprenal.00071.2016
Bichet DG, Bockenhauer D (2016) Genetic forms of nephrogenic diabetes insipidus (NDI): vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab 30:263–276. doi:10.1016/j.beem.2016.02.010
Blanchard A, Frank M, Wuerzner G, Peyrard S, Bankir L, Jeunemaitre X, Azizi M (2011) Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent. Clin J Am Soc Nephrol CJASN 6:753–759. doi:10.2215/CJN.06540810
Blankenstein KI, Borschewski A, Labes R, Paliege A, Boldt C, McCormick JA, Ellison DH, Bader M, Bachmann S, Mutig K (2016) Calcineurin inhibitor cyclosporine A activates renal Na-(K)-Cl cotransporters via local and systemic mechanisms. Am J Physiol Ren Physiol. doi:10.1152/ajprenal.00575.2016
Borschewski A, Himmerkus N, Boldt C, Blankenstein KI, McCormick JA, Lazelle R, Willnow TE, Jankowski V, Plain A, Bleich M, Ellison DH, Bachmann S, Mutig K (2016) Calcineurin and sorting-related receptor with A-type repeats interact to regulate the renal Na+-K+-2Cl− cotransporter. J Am Soc Nephrol JASN 27:107–119. doi:10.1681/ASN.2014070728
Caceres PS, Ares GR, Ortiz PA (2009) cAMP stimulates apical exocytosis of the renal Na(+)-K(+)-2Cl(−) cotransporter NKCC2 in the thick ascending limb: role of protein kinase A. J Biol Chem 284:24965–24971. doi:10.1074/jbc.M109.037135
Caceres PS, Mendez M, Haque MZ, Ortiz PA (2016) Vesicle-associated membrane protein 3 (VAMP3) mediates constitutive trafficking of the renal co-transporter NKCC2 in thick ascending limbs: role in renal function and blood pressure. J Biol Chem 291:22063–22073. doi:10.1074/jbc.M116.735167
Caceres PS, Mendez M, Ortiz PA (2014) Vesicle-associated membrane protein 2 (VAMP2) but not VAMP3 mediates cAMP-stimulated trafficking of the renal Na+-K+-2Cl- co-transporter NKCC2 in thick ascending limbs. J Biol Chem 289:23951–23962. doi:10.1074/jbc.M114.589333
Carmosino M, Rizzo F, Procino G, Basco D, Valenti G, Forbush B, Schaeren-Wiemers N, Caplan MJ, Svelto M (2010) MAL/VIP17, a new player in the regulation of NKCC2 in the kidney. Mol Biol Cell 21:3985–3997. doi:10.1091/mbc.E10-05-0456
Castrop H, Schnermann J (2008) Isoforms of renal Na-K-2Cl cotransporter NKCC2: expression and functional significance. Am J Physiol Ren Physiol 295:F859–F866. doi:10.1152/ajprenal.00106.2008
Cheng L, Wu Q, Kortenoeven MLA, Pisitkun T, Fenton RA (2015) A systems level analysis of vasopressin-mediated signaling networks in kidney distal convoluted tubule cells. Sci Rep 5:12829. doi:10.1038/srep12829
Dathe C, Daigeler A-L, Seifert W, Jankowski V, Mrowka R, Kalis R, Wanker E, Mutig K, Bachmann S, Paliege A (2014) Annexin A2 mediates apical trafficking of renal Na+-K+-2Cl− cotransporter. J Biol Chem 289:9983–9997. doi:10.1074/jbc.M113.540948
Deen PM, Knoers NV (1998) Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus. Am J Med Sci 316:300–309
Douglass J, Gunaratne R, Bradford D, Saeed F, Hoffert JD, Steinbach PJ, Knepper MA, Pisitkun T (2012) Identifying protein kinase target preferences using mass spectrometry. Am J Phys Cell Phys 303:C715–C727. doi:10.1152/ajpcell.00166.2012
Drücker P, Pejic M, Galla H-J, Gerke V (2013) Lipid segregation and membrane budding induced by the peripheral membrane binding protein annexin A2. J Biol Chem 288:24764–24776. doi:10.1074/jbc.M113.474023
Drücker P, Pejic M, Grill D, Galla H-J, Gerke V (2014) Cooperative binding of annexin A2 to cholesterol- and phosphatidylinositol-4,5-bisphosphate-containing bilayers. Biophys J 107:2070–2081. doi:10.1016/j.bpj.2014.08.027
Ecelbarger CA, Kim GH, Terris J, Masilamani S, Mitchell C, Reyes I, Verbalis JG, Knepper MA (2000) Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Ren Physiol 279:F46–F53
Ecelbarger CA, Kim GH, Wade JB, Knepper MA (2001) Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Neurol 171:227–234. doi:10.1006/exnr.2001.7775
Ellison DH, Loffing J (2009) Thiazide effects and adverse effects: insights from molecular genetics. Hypertension 54:196–202. doi:10.1161/HYPERTENSIONAHA.109.129171
Fernandes S, Bruneval P, Hagege A, Heudes D, Ghostine S, Bouby N (2002) Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension. Endocrinology 143:2759–2766. doi:10.1210/endo.143.7.8918
Fryckstedt J, Meister B, Aperia A (1992) Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32. J Auton Pharmacol 12:183–189
Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, Hebert SC (1994) Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 269:17713–17722
Giménez I, Forbush B (2003) Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J Biol Chem 278:26946–26951. doi:10.1074/jbc.M303435200
Giménez I, Forbush B (2005) Regulatory phosphorylation sites in the NH2 terminus of the renal Na-K-Cl cotransporter (NKCC2). Am J Physiol Ren Physiol 289:F1341–F1345. doi:10.1152/ajprenal.00214.2005
Gunaratne R, Braucht DWW, Rinschen MM, Chou C-L, Hoffert JD, Pisitkun T, Knepper MA (2010) Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc Natl Acad Sci U S A 107:15653–15658. doi:10.1073/pnas.1007424107
Hadchouel J, Ellison DH, Gamba G (2016) Regulation of renal electrolyte transport by WNK and SPAK-OSR1 kinases. Annu Rev Physiol 78:367–389. doi:10.1146/annurev-physiol-021115-105431
Halpain S, Girault JA, Greengard P (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343:369–372. doi:10.1038/343369a0
Hebert SC, Andreoli TE (1984) Effects of antidiuretic hormone on cellular conductive pathways in mouse medullary thick ascending limbs of Henle: II. Determinants of the ADH-mediated increases in transepithelial voltage and in net Cl-absorption. J Membr Biol 80:221–233
Hoorn EJ, Walsh SB, McCormick JA, Fürstenberg A, Yang C-L, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17:1304–1309. doi:10.1038/nm.2497
Igarashi P, Whyte DA, Li K, Nagami GT (1996) Cloning and kidney cell-specific activity of the promoter of the murine renal Na-K-C1 cotransporter gene. J Biol Chem 271:9666–9674
Klein JD, Fröhlich O, Blount MA, Martin CF, Smith TD, Sands JM (2006) Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol JASN 17:2680–2686. doi:10.1681/ASN.2006030246
Kortenoeven MLA, Pedersen NB, Rosenbaek LL, Fenton RA (2015) Vasopressin regulation of sodium transport in the distal nephron and collecting duct. Am J Physiol Ren Physiol 309:F280–F299. doi:10.1152/ajprenal.00093.2015
Lazelle RA, McCully BH, Terker AS, Himmerkus N, Blankenstein KI, Mutig K, Bleich M, Bachmann S, Yang C-L, Ellison DH (2016) Renal deletion of 12 kDa FK506-binding protein attenuates tacrolimus-induced hypertension. J Am Soc Nephrol JASN 27:1456–1464. doi:10.1681/ASN.2015040466
Lin S-H, Yu I-S, Jiang S-T, Lin S-W, Chu P, Chen A, Sytwu H-K, Sohara E, Uchida S, Sasaki S, Yang S-S (2011) Impaired phosphorylation of Na(+)-K(+)-2Cl(−) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. Proc Natl Acad Sci U S A 108:17538–17543. doi:10.1073/pnas.1107452108
Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M, International Consortium for Blood Pressure (ICBP), Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott J-J, Jeunemaitre X (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44(456–460):S1–S3. doi:10.1038/ng.2218
McCormick JA, Ellison DH (2015) Distal convoluted tubule. Compr Physiol 5:45–98. doi:10.1002/cphy.c140002
McCormick JA, Mutig K, Nelson JH, Saritas T, Hoorn EJ, Yang C-L, Rogers S, Curry J, Delpire E, Bachmann S, Ellison DH (2011) A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab 14:352–364. doi:10.1016/j.cmet.2011.07.009
Milatz S, Himmerkus N, Wulfmeyer VC, Drewell H, Mutig K, Hou J, Breiderhoff T, Müller D, Fromm M, Bleich M, Günzel D (2017) Mosaic expression of claudins in thick ascending limbs of Henle results in spatial separation of paracellular Na+ and Mg2+ transport. Proc Natl Acad Sci U S A 114:E219–E227. doi:10.1073/pnas.1611684114
Moes AD, van der Lubbe N, Zietse R, Loffing J, Hoorn EJ (2014) The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation. Pflugers Arch 466:107–118. doi:10.1007/s00424-013-1407-9
Monette MY, Rinehart J, Lifton RP, Forbush B (2011) Rare mutations in the human Na-K-Cl cotransporter (NKCC2) associated with lower blood pressure exhibit impaired processing and transport function. Am J Physiol Ren Physiol 300:F840–F847. doi:10.1152/ajprenal.00552.2010
Morel A, Lolait SJ, Brownstein MJ (1993) Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors. Regul Pept 45:53–59
Morel F (1981) Sites of hormone action in the mammalian nephron. Am J Phys 240:F159–F164
Mutig K, Borowski T, Boldt C, Borschewski A, Paliege A, Popova E, Bader M, Bachmann S (2016) Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach. Am J Physiol Ren Physiol 311:F411–F423. doi:10.1152/ajprenal.00126.2016
Mutig K, Kahl T, Saritas T, Godes M, Persson P, Bates J, Raffi H, Rampoldi L, Uchida S, Hille C, Dosche C, Kumar S, Castaneda-Bueno M, Gamba G, Bachmann S (2011) Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. J Biol Chem 286:30200–30210. doi:10.1074/jbc.M111.222968
Mutig K, Paliege A, Kahl T, Jöns T, Müller-Esterl W, Bachmann S (2007) Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Ren Physiol 293:F1166–F1177. doi:10.1152/ajprenal.00196.2007
Mutig K, Saritas T, Uchida S, Kahl T, Borowski T, Paliege A, Böhlick A, Bleich M, Shan Q, Bachmann S (2010) Short-term stimulation of the thiazide-sensitive Na+-Cl- cotransporter by vasopressin involves phosphorylation and membrane translocation. Am J Physiol Ren Physiol 298:F502–F509. doi:10.1152/ajprenal.00476.2009
Nicco C, Wittner M, DiStefano A, Jounier S, Bankir L, Bouby N (2001) Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Hypertension Dallas Tex 38:1143–1149
Ostrowski NL, Young WS, Knepper MA, Lolait SJ (1993) Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats. Endocrinology 133:1849–1859. doi:10.1210/endo.133.4.8404628
Pearce D, Soundararajan R, Trimpert C, Kashlan OB, Deen PMT, Kohan DE (2015) Collecting duct principal cell transport processes and their regulation. Clin J Am Soc Nephrol CJASN 10:135–146. doi:10.2215/CJN.05760513
Pedersen NB, Hofmeister MV, Rosenbaek LL, Nielsen J, Fenton RA (2010) Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule. Kidney Int 78:160–169. doi:10.1038/ki.2010.130
Picard N, Trompf K, Yang C-L, Miller RL, Carrel M, Loffing-Cueni D, Fenton RA, Ellison DH, Loffing J (2014) Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotension. J Am Soc Nephrol JASN 25:511–522. doi:10.1681/ASN.2012121202
Rescher U, Gerke V (2004) Annexins—unique membrane binding proteins with diverse functions. J Cell Sci 117:2631–2639. doi:10.1242/jcs.01245
Richardson C, Sakamoto K, de los Heros P, Deak M, Campbell DG, Prescott AR, Alessi DR (2011) Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci 124:789–800. doi:10.1242/jcs.077230
Rieg T, Tang T, Uchida S, Hammond HK, Fenton RA, Vallon V (2013) Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC. Am J Pathol 182:96–106. doi:10.1016/j.ajpath.2012.09.014
Roald AB, Tenstad O, Aukland K (2004) The effect of AVP-V receptor stimulation on local GFR in the rat kidney. Acta Physiol Scand 182:197–204. doi:10.1111/j.1365-201X.2004.01352.x
Robben JH, Knoers NVAM, Deen PMT (2006) Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Ren Physiol 291:F257–F270. doi:10.1152/ajprenal.00491.2005
Rosenbaek LL, Kortenoeven MLA, Aroankins TS, Fenton RA (2014) Phosphorylation decreases ubiquitylation of the thiazide-sensitive cotransporter NCC and subsequent clathrin-mediated endocytosis. J Biol Chem 289:13347–13361. doi:10.1074/jbc.M113.543710
Sands JM, Layton HE (2014) Advances in understanding the urine-concentrating mechanism. Annu Rev Physiol 76:387–409. doi:10.1146/annurev-physiol-021113-170350
Saritas T, Borschewski A, McCormick JA, Paliege A, Dathe C, Uchida S, Terker A, Himmerkus N, Bleich M, Demaretz S, Laghmani K, Delpire E, Ellison DH, Bachmann S, Mutig K (2013) SPAK differentially mediates vasopressin effects on sodium cotransporters. J Am Soc Nephrol JASN 24:407–418. doi:10.1681/ASN.2012040404
Schnermann J, Briggs JP (2008) Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice. Kidney Int 74:418–426. doi:10.1038/ki.2008.145
Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996) Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13:183–188. doi:10.1038/ng0696-183
Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP (1996) Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12:24–30. doi:10.1038/ng0196-24
Terker AS, Zhang C, McCormick JA, Lazelle RA, Zhang C, Meermeier NP, Siler DA, Park HJ, Fu Y, Cohen DM, Weinstein AM, Wang W-H, Yang C-L, Ellison DH (2015) Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab 21:39–50. doi:10.1016/j.cmet.2014.12.006
Tiwari S, Packer RK, Hu X, Sugimura Y, Verbalis JG, Ecelbarger CA (2006) Increased renal alpha-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape. Am J Physiol Ren Physiol 291:F49–F57. doi:10.1152/ajprenal.00390.2005
Trudu M, Janas S, Lanzani C, Debaix H, Schaeffer C, Ikehata M, Citterio L, Demaretz S, Trevisani F, Ristagno G, Glaudemans B, Laghmani K, Dell’Antonio G, Swiss Kidney Project on Genes in Hypertension (SKIPOGH) team, Loffing J, Rastaldi MP, Manunta P, Devuyst O, Rampoldi L (2013) Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med 19:1655–1660. doi:10.1038/nm.3384
Vidal-Petiot E, Elvira-Matelot E, Mutig K, Soukaseum C, Baudrie V, Wu S, Cheval L, Huc E, Cambillau M, Bachmann S, Doucet A, Jeunemaitre X, Hadchouel J (2013) WNK1-related familial hyperkalemic hypertension results from an increased expression of L-WNK1 specifically in the distal nephron. Proc Natl Acad Sci U S A 110:14366–14371. doi:10.1073/pnas.1304230110
Welker P, Böhlick A, Mutig K, Salanova M, Kahl T, Schlüter H, Blottner D, Ponce-Coria J, Gamba G, Bachmann S (2008) Renal Na+-K+-Cl- cotransporter activity and vasopressin-induced trafficking are lipid raft-dependent. Am J Physiol Ren Physiol 295:F789–F802. doi:10.1152/ajprenal.90227.2008
Wilson FH, Disse-Nicodème S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107–1112. doi:10.1126/science.1062844
Acknowledgements
We would like to acknowledge Martin Thomson and Torsten Giesecke for constructive discussions and technical help.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial support and sponsorship
The present study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG: MU 2924/2-2 and BA 700/22-2).
Conflict of interests
The authors declare that they have no conflicts of interest.
Additional information
This article is part of the special issue on Functional Anatomy of the Kidney in Health and Disease in Pflügers Archiv – European Journal of Physiology
Rights and permissions
About this article
Cite this article
Bachmann, S., Mutig, K. Regulation of renal Na-(K)-Cl cotransporters by vasopressin. Pflugers Arch - Eur J Physiol 469, 889–897 (2017). https://doi.org/10.1007/s00424-017-2002-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-017-2002-2